Orthocell Share Price Up 25% on FDA Approval (ASX:OCC)
Drug development is a long and tedious process, often taking years to reach commercialisation. Small-cap biotech company Orthocell Ltd [ASX:OCC] knows this all too well, having spent years bringing their tissue repair...